RxDoctor Payments Data

Tiffany Lindsay

Psychiatric/Mental Health · Gastonia, NCNPI 1821769894

Payments from drug & device makers

$495in general payments, 2019–2025

Across 29 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$197
  • Otsuka America Pharmaceutical, Inc.$72
  • Alkermes, Inc.$45
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$41
  • Tris Pharma Inc$23
  • Sunovion Pharmaceuticals Inc.$19
  • plus $97 from 6 others

What the payments were for

  • Food & beverage$495100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$495 in reported general payments places this provider in the 50th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$12,387
Medicare patients
18
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate13$5,193
Quetiapine Fumarate ErQuetiapine Fumarate12$868
Aripiprazole16$762
Oxcarbazepine13$759
Hydroxyzine Hcl27$684
Buspirone Hcl41$536
Duloxetine Hcl19$280
Risperidone22$267
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$261
Prazosin Hcl22$256
Clonazepam41$255
Hydroxyzine Pamoate26$220
Diazepam24$209
Quetiapine Fumarate13$186
Venlafaxine Hcl ErVenlafaxine Hcl24$161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$15$5,19313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →